Livzon Pharmaceutical Group (HK:1513) has released an update.
Livzon Pharmaceutical Group Inc. has announced the composition of its Board of Directors, including executive, non-executive, and independent members. Additionally, the company disclosed the membership details of its five key committees: Audit, Remuneration and Assessment, Nomination, Strategy, and Environmental, Social, and Governance. The committees are chaired by a mix of directors, ensuring a diverse oversight structure.
For further insights into HK:1513 stock, check out TipRanks’ Stock Analysis page.
